GYRE
Financials
- Market Capitalization 734.85 M
- Employee 618
- Founded 1997
- CEO N/A
- Website www.gyretx.com
- Headquarter Delaware, United States
- FIGI BBG000F88SY8
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2657 |  MNPR Monopar Therapeutics Inc. - Common Stock | 111.89 USD | -1.80% | +4.60% | +3.63% | +104.85% | 751.02 M USD | ||
| 2667 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 9.18 USD | +2.68% | +3.38% | +3.15% | -23.37% | 742.67 M USD | ||
| 2677 |  NGNE Neurogene Inc. - Common Stock | 36.58 USD | -3.38% | -5.33% | +8.71% | +24.34% | 732.02 M USD | ||
| 2697 |  STTK Shattuck Labs, Inc. - Common Stock | 7.04 USD | -7.97% | -8.09% | +2.77% | +611.11% | 706.56 M USD |
Frequently asked questions about Gyre Therapeutics, Inc. Common Stock
What is the Gyre Therapeutics, Inc. Common Stock stock price today?
The current price of Gyre Therapeutics, Inc. Common Stock (GYRE) is 6.59. Over the past 24 hours, the stock has changed by -1.35%. Follow the GYRE chart for real-time price dynamics.
What is the stock ticker of Gyre Therapeutics, Inc. Common Stock?
Gyre Therapeutics, Inc. Common Stock trades under the ticker GYRE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Gyre Therapeutics, Inc. Common Stock stock going up?
GYRE has changed by -4.35% over the last week, +15.21% over the last month, and -20.22% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Gyre Therapeutics, Inc. Common Stock?
Gyre Therapeutics, Inc. Common Stock currently has a market capitalization of 734.85 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
Does Gyre Therapeutics, Inc. Common Stock release financial reports?
Yes. You can track Gyre Therapeutics, Inc. Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What were Gyre Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Gyre Therapeutics, Inc. Common Stock reported earnings of -0.12 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Gyre Therapeutics, Inc. Common Stock revenue for the last quarter?
Gyre Therapeutics, Inc. Common Stock reported quarterly revenue of 29.84 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Gyre Therapeutics, Inc. Common Stock net income for the last quarter?
Gyre Therapeutics, Inc. Common Stock reported net income of -14.27 M for the last quarter. The previous quarter showed -9.86 M, which means net income changed by -44.76%.
How many employees does Gyre Therapeutics, Inc. Common Stock have?
As of the latest available data, Gyre Therapeutics, Inc. Common Stock has 618 employees. Workforce size can provide additional context about the company's scale and operations.
What is Gyre Therapeutics, Inc. Common Stock EBITDA?
Gyre Therapeutics, Inc. Common Stock EBITDA is -12.14 M, and its EBITDA margin is -40.68%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Gyre Therapeutics, Inc. Common Stock stock?
You can buy Gyre Therapeutics, Inc. Common Stock (GYRE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Gyre Therapeutics, Inc. Common Stock stock?
Investing in Gyre Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GYRE chart and related analysis on metatrader.com as part of your research.